INS and Insulin resistance: Numerous studies have confirmed that BBR is a multi-target drug and its anti-diabetic activity is related to various mechanisms, including promoting insulin secretion, reducing insulin resistance, promoting glycolysis, inhibiting gluconeogenesis, inhibiting the inflammation response, and regulating intestinal microbial disturbance, etc (Xu et al., 2021).